|
Market Closed -
Bombay S.E.
11:02:20 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 194.80 INR | +0.91% |
|
+18.93% | +136.84% |
| Market Cap | 57.18B 598M 516M 483M 441M 831M 834M 5.73B 2.24B 28.86B 2.25B 2.2B 95.71B | P/E 2027 * |
26x | P/E 2028 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 57.18B 598M 516M 483M 441M 831M 834M 5.73B 2.24B 28.86B 2.25B 2.2B 95.71B | EV / Sales 2027 * |
2.09x | EV / Sales 2028 * | 1.81x |
| Free-Float |
33.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : IOL Chemicals and Pharmaceuticals Limited
| 1 day | +0.91% | ||
| 1 week | +18.93% | ||
| Current month | +33.24% | ||
| 1 month | +28.41% | ||
| 3 months | +48.32% | ||
| 6 months | +166.85% | ||
| Current year | +136.84% |
| 1 week | 167 | 197.05 | |
| 1 month | 143.55 | 197.05 | |
| Current year | 67.14 | 197.05 | |
| 1 year | 67.14 | 197.05 | |
| 3 years | 57.51 | 197.05 | |
| 5 years | 54.44 | 197.05 | |
| 10 years | 8.4 | 197.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 13/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 31/08/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 28/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.91% | +18.93% | +112.32% | +158.49% | 593M | ||
| -0.13% | -6.44% | +60.47% | +112.05% | 1,048B | ||
| +0.85% | -0.81% | +52.77% | +63.15% | 640B | ||
| -1.03% | -3.58% | +22.87% | +73.29% | 456B | ||
| -1.46% | -3.52% | +36.60% | +38.39% | 362B | ||
| -0.72% | -2.06% | +21.34% | +37.92% | 295B | ||
| -1.19% | -0.98% | +0.79% | +12.29% | 255B | ||
| -1.05% | -1.57% | +51.40% | +68.55% | 236B | ||
| +0.08% | -0.22% | -17.16% | -53.76% | 204B | ||
| -2.14% | -0.30% | +29.42% | +89.10% | 185B | ||
| Average | -0.50% | +0.86% | +37.08% | +59.95% | 368.22B | |
| Weighted average by Cap. | -0.45% | -1.92% | +38.44% | +65.55% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27.42B 287M 247M 232M 212M 399M 400M 2.75B 1.07B 13.84B 1.08B 1.05B 45.9B | 31.52B 330M 284M 266M 243M 458M 460M 3.16B 1.23B 15.91B 1.24B 1.21B 52.77B |
| Net income | 2.2B 23M 19.82M 18.58M 16.96M 31.95M 32.05M 220M 86.01M 1.11B 86.35M 84.47M 3.68B | 2.84B 29.72M 25.61M 24.01M 21.92M 41.29M 41.42M 285M 111M 1.43B 112M 109M 4.75B |
| Net Debt | - | - |
Employees
3,095
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | ₹194.80 | +0.91% | 314,308 |
| 27/08/26 | ₹193.05 | +3.76% | 730,932 |
| 26/08/26 | ₹186.05 | +7.89% | 904,029 |
| 25/08/26 | ₹172.45 | +1.92% | 285,009 |
| 24/08/26 | ₹169.20 | -0.21% | 291,080 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
194.80INR
Average target price
197.00INR
Spread / Average Target
+1.13%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions
















